World Heart day 2025

 

The primary goal of this global event is to raise awareness of cardiovascular diseases and their prevention at both the population and individual levels. Cardiovascular diseases are the leading cause of death worldwide, claiming 18 million lives annually, primarily among the working-age population.

The main slogan for World Heart Day 2025 is "Don't Miss a Moment." Loved ones around the world are missing out on time they should spend together due to early death from cardiovascular disease.

This event has been celebrated since the late 20th century and was initiated by the World Heart Federation. Subsequently, such reputable organizations as the WHO and UNESCO supported the idea. Currently, this event is celebrated in countries around the world.

In Russia, National Healthy Heart Week is being organized as part of this international event. Public events are held at various venues, and medical examinations are organized at medical institutions. Medical non-governmental organizations in Russia also actively participate in educational and sports events to promote healthy lifestyles among the population. This holiday is also widely covered in Russian media.

Since its inception, the Cardioprogress Foundation has actively collaborated with the World Heart Federation to celebrate this occasion, organizing events in various cities across the Russian Federation.

 

 

 

 

 
 

Scientific news

  • Can Antibiotics Wait for Blood Cultures in Endocarditis? In clinically stable patients with suspected or confirmed infective endocarditis (IE), deferring antimicrobial treatment until blood culture results were available was not associated with 30-day mortality or worse clinical outcomes compared with immediate antimicrobial treatment.
  • Statin Use May Mitigate Major Cardiovascular Event Risk With Tofacitinib in Rheumatoid Arthritis Most patients with rheumatoid arthritis (RA) and cardiovascular risk factors did not receive statins at baseline, and few initiated them later. Statin use in tofacitinib-treated patients with a history of atherosclerotic cardiovascular disease (ASCVD) was linked to fewer major adverse cardiovascular events (MACE). No difference in incident MACE was seen between tofacitinib users and TNF-inhibitor users when statins were used.
  • Gene Variants Drive Heart Risks in Polycystic Kidney Disease In patients with autosomal dominant polycystic kidney disease (ADPKD), left ventricular hypertrophy was independently associated with PKD1 gene mutations, and mitral valve prolapse was associated with truncating PKD1 mutations.
  • Pregabalin Tied to Elevated Heart Failure Risk The results of a recent study published in JAMA Network Open show a substantially higher risk for heart failure (HF) in people taking the antiseizure medication pregabalin for chronic noncancer pain. The risk is particularly high for people with preexisting cardiovascular disease.
  • Azoospermia May Signal Hidden Health Risks Azoospermia, the complete absence of sperm in the ejaculate, affects approximately 1 in 100 men and accounts for up to 20% of male infertility cases. Once considered only a fertility problem, azoospermia is now linked to broader health risks.

Partners

Video resource

Channel "Cardioprogress"

Follow us

Top.Mail.Ru